International Assets Investment Management LLC Purchases New Shares in Axon Enterprise, Inc. (NASDAQ:AXON)

International Assets Investment Management LLC acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 154,481 shares of the biotechnology company's stock, valued at approximately $39,907,000. International Assets Investment Management LLC owned about 0.21% of Axon Enterprise as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of AXON. BlackRock Inc. increased its position in shares of Axon Enterprise by 11.7% during the 1st quarter. BlackRock Inc. now owns 8,329,479 shares of the biotechnology company's stock valued at $1,872,883,000 after purchasing an additional 870,481 shares during the last quarter. State Street Corp increased its holdings in Axon Enterprise by 22.6% during the second quarter. State Street Corp now owns 2,915,214 shares of the biotechnology company's stock valued at $568,817,000 after buying an additional 538,119 shares during the last quarter. Capital International Investors raised its position in Axon Enterprise by 605.2% in the first quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company's stock worth $366,449,000 after acquiring an additional 2,283,343 shares during the period. Sands Capital Management LLC boosted its stake in shares of Axon Enterprise by 31.1% during the 3rd quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company's stock worth $519,823,000 after acquiring an additional 619,179 shares during the last quarter. Finally, Wellington Management Group LLP boosted its stake in shares of Axon Enterprise by 3.3% during the 3rd quarter. Wellington Management Group LLP now owns 1,956,022 shares of the biotechnology company's stock worth $389,229,000 after acquiring an additional 62,324 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Wall Street Analysts Forecast Growth

AXON has been the subject of several analyst reports. JMP Securities upped their price objective on Axon Enterprise from $250.00 to $285.00 and gave the stock a "market outperform" rating in a research note on Tuesday, February 6th. StockNews.com downgraded Axon Enterprise from a "buy" rating to a "hold" rating in a research note on Thursday, March 14th. Needham & Company LLC lifted their price objective on Axon Enterprise from $240.00 to $315.00 and gave the company a "buy" rating in a research report on Wednesday, February 28th. TheStreet downgraded Axon Enterprise from a "b" rating to a "c+" rating in a research note on Tuesday, February 27th. Finally, Argus started coverage on shares of Axon Enterprise in a research note on Wednesday, March 13th. They set a "buy" rating and a $380.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and a consensus price target of $301.73.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded up $0.06 on Tuesday, hitting $311.27. 304,536 shares of the company traded hands, compared to its average volume of 461,053. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $325.63. The business has a 50-day simple moving average of $293.53 and a 200 day simple moving average of $252.60. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The stock has a market capitalization of $23.49 billion, a P/E ratio of 135.34 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.29. The company had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. Research analysts expect that Axon Enterprise, Inc. will post 2.43 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.